Journal article
Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children
Abstract
OBJECTIVE: To determine whether 0.5 mg/kg insulin-like growth factor (IGF)-1/binding protein (IGFBP)-3, given intravenously, effectively alters the acute phase response in severely burned children.
DESIGN: Longitudinal trial with each patient serving as their own control.
Authors
Spies M; Wolf SE; Barrow RE; Jeschke MG; Herndon DN
Journal
Critical Care Medicine, Vol. 30, No. 1, pp. 83–88
Publisher
Wolters Kluwer
Publication Date
January 2002
DOI
10.1097/00003246-200201000-00013
ISSN
0090-3493